Can a DIY fertility test help you plan when to have a baby?
By Zoë Corbyn,
The Guardian
| 01. 21. 2018
My sisters, aged 27 and 30, are seated at their computers poring over the slick websites of companies promising to reveal secrets to them about their fertility. “Get insight into how your fertility is tracking relative to your age,” promises one. “Get the tools you need to have more control over your fertility,” says a second. “Gauge how long you have left to conceive,” says a third. The tests, which look at the levels of one or more female hormones in the blood, style themselves as easy to order and are less than what one would pay in a fertility clinic. “The information seems relatively cheap and readily available, so why not find out?” says my older sister. “I just assumed I wouldn’t have any fertility issues,” says the younger. “I realise after looking at these websites I probably shouldn’t assume this.”
These companies are the latest outgrowth of the growing global market in fertility services. Fuelled by women delaying childbirth longer, it includes IVF and egg freezing and is expected to generate $21bn (£15.5bn) in revenue globally by 2020...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...